This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Stimulus: Biggest Win, Believe it Or Not, Was Shareholder Value

NEW YORK (TheStreet) -- The final White House report on the effect of the 2009 stimulus came out last week, and was met with a collective yawn. President Obama's Council of Economic Advisers said the $763 billion of tax cuts and spending created or saved 1.6 million jobs a year.

Eeveryone played their assigned role: The New York Times editorial board tut-tutted the remaining doubters, while the libertarian Cato Institute called the analysis "fairy dust''.

But after Washington's windbags have their respective says, we are left with this: Stocks aided by the stimulus have clobbered the market since 2009. In the real world, results like that matter. The business headlines -- not the political ones -- are riddled with success stories that far outweigh the scattered failures of stimulus-backed companies that went bust. As Ronald Reagan once said (on the second try), facts are stubborn things.*

Indeed, back in 2011 I asked tech-consulting shop IDC to put together a list of companies that had been top beneficiaries of the $100 billion IDC estimated that the stimulus would prompt spend on technology -- almost all of it for electronic medical records and new energy technologies. Along with road construction, unemployment insurance and aid to state budgets, this was the biggest chunk of stimulus spending. Then I plugged in their stock prices when President Barack Obama took office in 2009. Here are some highlights of what happened, through Friday's close.

  • A model portfolio of top health-care information technology companies identified by IDC has more than tripled. (In each example here, I assumed I had bought 100 shares of each company, and the results compare to a 99% gain in the Dow Jones Industrial Average). Of these, the top performer was Athenahealth (ATHN), up 476%. (Athenahealth is a political bastard child, co-founded by President George W. Bush's cousin and President Obama's top technology aide).
  • A portfolio of the three now-public companies that took loan money to build factories for next-generation autos has climbed 14-fold. This gain is driven mostly by Tesla (TSLA) -- which built its Model S factory with a government loan deal that included since-redeemed warrants that would have let the government buy Tesla shares for $7.53, or just a smidge below Friday's close of $209.60. The 612% gain for Ford (F), which used stimulus-related financing to refit factories to make fuel-saving EcoBoost engines, and the 159% gain for Nissan (making electric-powered Leafs in a Tennessee plant financed with Energy Department loan guarantees) are just gravy.
  • I count 11 post-2009 initial public offerings of companies that took stimulus money. Most have stumbled after going public -- the list includes at least four biofuels companies and electric car battery maker A123 Systems, which declared bankruptcy. But Tesla's epic performance and SolarCity's (SCTY) climb to $76 from an $8 IPO in 2012 means the list as a whole has jumped almost 120%.  (SolarCity's customers for home-based solar systems could get grants under the stimulus, in lieu of tax breaks).
  • When solar-panel maker Solyndra went broke before it could stage a planned IPO, defaulting on its $535 million stimulus loan to build its factory, Washington made much of a memo from ex-Obama aide Larry Summers saying "government is crappy VC.'' The argument was that the administration couldn't capably do what venture capitalists do to seed the economy. Solyndra wasn't the only failure. Vehicle Production Group (a startup that made natural-gas powered vehicles for the disabled), Fisker Automotive, and A123 all went bankrupt, too.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs